このエントリーをはてなブックマークに追加


ID 69877
FullText URL
Author
Kubo, Toru Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University
Maekawa, Yuichiro Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine
Hongo, Kenichi Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine
Yamamoto, Saori Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
Izumiya, Yasuhiro Department of Cardiovascular Medicine, Osaka Metropolitan University, Graduate School of Medicine
Yamakawa, Hiroyuki Department of Cardiology, Keio University School of Medicine
Yano, Toshiyuki Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine
Higuchi, Koji Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University
Kuramoto, Yuki Department of Cardiovascular Medicine, The University of Osaka Graduate School of Medicine
Nakagawa, Naoki Division of Cardiology and Nephrology, Department of Internal Medicine, Asahikawa Medical University
Amano, Masashi Department of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center
Yamada, Yu Department of Cardiology, Institute of Medicine, University of Tsukuba
Oikawa, Masayoshi Department of Cardiovascular Medicine, Fukushima Medical University
Iida, Yuichiro Department of Cardiovascular Medicine, Kitasato University School of Medicine
Tsujita, Kenichi Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
Matsue, Yuya Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine
Izawa, Hideo Department of Cardiology, Fujita Health University
Suzuki, Atsushi Department of Cardiology, Tokyo Women's Medical University
Nagatomo, Yuji Department of Cardiology, National Defense Medical College
Nagai, Toshiyuki Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University
Kida, Keisuke Department of Pharmacology, St. Marianna University School of Medicine
Nakamura, Kazuto Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine
Nakamura, Kazufumi Center for Advanced Heart Failure, Okayama University Hospital Kaken ID publons researchmap
Ikenaga, Hiroki Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences
Kanda, Takahiro Department of Internal Medicine, Division of Cardiology, Hamamatsu Red Cross Hospital
Kinugasa, Yoshiharu Department of Cardiovascular Medicine and Endocrinology and Metabolism, Faculty of Medicine, Tottori University
Ito, Hiromasa Department of Cardiology, Mie University Hospital
Onoue, Kenji Department of Cardiovascular Medicine, Nara Medical University
Kanamori, Hiromitsu Department of Cardiology, Gifu University Graduate School of Medicine
Kitaoka, Hiroaki Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University
Abstract
Background: Fabry disease (FD) is an important disease in the cardiovascular field because a significant proportion of patients with FD die from cardiac lesions.
Methods: A multicenter prospective registration study of patients with FD throughout Japan was designed. The baseline clinical characteristics of 175 patients are presented here.
Results: The mean ages at enrolment and at diagnosis were 52 ± 16 and 43 ± 18 years, respectively, with men accounting for 38 % of the patients. In the cohort, 24 % of the patients had the classical hemizygote male type, whereas 14 % had the late-onset male type, and 62 % had the heterozygote female type. On electrocardiography data at enrolment in 92 patients with left ventricular hypertrophy (LVH) (maximum LV wall thickness > 12 mm), 12 % showed a short PQ interval (< 120 msec), and 33 % had a short PendQ interval (≤ 40 msec). The Sokolow-Lyon voltage was high (6.1 ± 13.1 mv). Regarding the distribution of LVH patterns, 77 % of the patients showed concentric diffuse LVH, 16 % of the patients had asymmetric septal hypertrophy, and 1 % of the patients had hypertrophy confined to the LV apex. With regard to implantation of cardiac devices, permanent pacemakers had been implanted in 5 % of the patients and defibrillators had been implanted in 12 patients (7 %), for primary prevention in nine patients and for secondary prevention in three patients.
Conclusion: As the first large-scale prospective registry of FD patients in Japan, this study has provided valuable baseline data for the cardiac features and management of FD.
Keywords
Fabry disease
Prospective study
Left ventricular hypertrophy
Treatment
Published Date
2026-02-15
Publication Title
International Journal of Cardiology
Volume
volume445
Publisher
Elsevier BV
Start Page
134071
ISSN
0167-5273
NCID
AA10623832
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2025 The Authors.
File Version
publisher
PubMed ID
DOI
Related Url
isVersionOf https://doi.org/10.1016/j.ijcard.2025.134071
License
http://creativecommons.org/licenses/by/4.0/